Takayuki Hara Selected Research

Takayuki Hara Research Topics

Disease

6	Neoplasms (Cancer) 06/2023 - 07/2006
5	Aneurysm (Aneurysms) 06/2023 - 01/2016
2	Pheochromocytoma 10/2022 - 01/2017
2	Hypothyroidism 01/2022 - 01/2020
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021 - 01/2016
2	Adenoma (Adenomas) 10/2017 - 03/2012
1	Cauda Equina Syndrome 11/2023
1	Paralysis (Palsy) 11/2023
1	Hemorrhage 06/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Philadelphia Chromosome 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Paraganglioma (Paragangliomas) 10/2022
1	Neoplasm Metastasis (Metastasis) 10/2022
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Hyperthyroidism 01/2022
1	Arteriosclerosis 06/2020
1	Wounds and Injuries (Trauma) 06/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2020
1	Arteriovenous Malformations (Arteriovenous Malformation) 10/2019
1	Exophthalmos (Proptosis) 01/2019
1	Cerebral Hemorrhage 01/2019
1	Rupture 10/2017
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 10/2017
1	Arteriovenous Fistula 03/2016
1	Triple Negative Breast Neoplasms 03/2014
1	Breast Neoplasms (Breast Cancer) 03/2014
1	Infections 07/2013
1	Mycoses (Diseases, Fungus) 07/2013
1	Pathologic Complete Response 10/2012
1	Proteinuria 10/2012
1	Lupus Nephritis 10/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2012
1	Chordoma 07/2006
1	Congenital Adrenal Insufficiency 08/2002

Drug/Important Bio-Agent (IBA)

2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 10/2012
2	CatecholaminesIBA 10/2022 - 01/2017
2	CreatinineIBA 01/2020 - 10/2012
2	SteroidsIBA 01/2020 - 01/2017
1	Methylprednisolone FDA LinkGeneric 11/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	nilotinib FDA Link 01/2023
1	Messenger RNA (mRNA)IBA 10/2022
1	CateninsIBA 10/2022
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2022
1	Phosphotransferases (Kinase)IBA 10/2022
1	Dopamine (Intropin)FDA LinkGeneric 10/2022
1	EnzymesIBA 10/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Gallium-67IBA 01/2020
1	pembrolizumabIBA 01/2020
1	Cystatin CIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 10/2017
1	MelatoninIBA 01/2017
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2017
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2016
1	LycopeneIBA 03/2014
1	Carotenoids (Carotene)IBA 03/2014
1	cytochrome P-450 CYP93C2 (Glycyrrhiza echinata)IBA 07/2013
1	Dihydrotachysterol (AT 10)IBA 07/2013
1	IsoflavonesIBA 07/2013
1	Serum AlbuminIBA 10/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2012
1	anti-dsDNA autoantibodyIBA 10/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2012
1	mizoribineIBA 10/2012
1	Capsules (Microcapsules)IBA 03/2012
1	Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA 08/2002

Therapy/Procedure

4	Therapeutics 11/2023 - 10/2012
2	Radiotherapy 06/2020 - 07/2006
2	Cerebral Revascularization 10/2017 - 01/2016
1	Ligation 06/2023
1	Carotid Endarterectomy 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Stents 01/2021
1	Conservative Treatment 10/2019
1	Craniotomy 01/2019
1	Perioperative Period 10/2017
1	Adjuvant Radiotherapy 10/2017